Mirum Pharmaceuticals, Inc. (MIRM)
93.33
-1.28
(-1.35%)
USD |
NASDAQ |
Nov 12, 16:00
93.22
-0.11
(-0.12%)
After-Hours: 20:00
Mirum Pharmaceuticals Price : 93.33 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 93.54 | 95.06 | 92.13 | 93.33 | 392856.0 |
| Nov 11, 2026 | 94.51 | 95.36 | 93.26 | 94.61 | 528482.0 |
| Nov 10, 2026 | 92.64 | 95.39 | 91.46 | 94.42 | 626646.0 |
| Nov 09, 2026 | 95.10 | 95.10 | 91.53 | 93.18 | 709690.0 |
| Nov 06, 2026 | 93.14 | 95.68 | 91.18 | 93.72 | 722721.0 |
| Nov 05, 2026 | 96.72 | 98.97 | 93.33 | 93.54 | 871315.0 |
| Nov 04, 2026 | 83.13 | 97.26 | 83.13 | 96.97 | 1.154M |
| Nov 03, 2026 | 85.89 | 88.54 | 85.89 | 87.03 | 635550.0 |
| Nov 02, 2026 | 85.55 | 86.52 | 83.68 | 85.74 | 522775.0 |
| Oct 30, 2026 | 85.21 | 87.49 | 84.12 | 85.00 | 673432.0 |
| Oct 29, 2026 | 86.72 | 88.51 | 84.66 | 86.39 | 591323.0 |
| Oct 28, 2026 | 85.00 | 86.63 | 84.28 | 85.81 | 535233.0 |
| Oct 27, 2026 | 83.27 | 85.62 | 82.18 | 85.56 | 563279.0 |
| Oct 26, 2026 | 81.76 | 83.47 | 81.16 | 83.27 | 429984.0 |
| Oct 23, 2026 | 82.39 | 83.00 | 80.24 | 80.39 | 788216.0 |
| Oct 22, 2026 | 83.26 | 84.86 | 82.58 | 83.10 | 420914.0 |
| Oct 21, 2026 | 85.16 | 85.84 | 82.86 | 83.44 | 646891.0 |
| Oct 20, 2026 | 82.75 | 85.55 | 82.32 | 85.07 | 633304.0 |
| Oct 19, 2026 | 80.90 | 82.89 | 80.34 | 82.24 | 417902.0 |
| Oct 16, 2026 | 82.48 | 82.48 | 79.64 | 80.14 | 462948.0 |
| Oct 15, 2026 | 82.10 | 83.48 | 81.00 | 82.39 | 605246.0 |
| Oct 14, 2026 | 78.41 | 81.90 | 78.35 | 79.96 | 975117.0 |
| Oct 13, 2026 | 86.06 | 87.00 | 79.51 | 79.62 | 762634.0 |
| Oct 12, 2026 | 87.22 | 88.31 | 81.95 | 86.06 | 1.212M |
| Oct 09, 2026 | 81.01 | 87.79 | 81.01 | 86.01 | 1.140M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 121.70 |
| Galectin Therapeutics, Inc. | 3.14 |
| TG Therapeutics, Inc. | 64.56 |
| Ardelyx, Inc. | 3.12 |
| Kodiak Sciences, Inc. | 108.25 |
Price Related Metrics
| PS Ratio | 8.326 |
| PEG Ratio | -0.0037 |
| Earnings Yield | -16.31% |
| Market Cap | 6.086B |
| PEGY Ratio | -0.0037 |